Platinum-resistant fallopian tube cancer

Clinical trials for Platinum-resistant fallopian tube cancer explained in plain language.

Never miss a new study

Get alerted when new Platinum-resistant fallopian tube cancer trials appear

Sign up with your email to follow new studies for Platinum-resistant fallopian tube cancer, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 3 Not yet recruiting 1 Not yet finished but already full! 1 Completed 1

New hope for hard-to-treat ovarian cancer: targeted drug shows promise in early trial

Disease control Ongoing

This study tests a drug called sacituzumab govitecan in 20 people with ovarian, fallopian tube, or primary peritoneal cancer that has stopped responding to platinum-based chemotherapy. The drug works like a guided missile, delivering chemotherapy directly to cancer cells. The mai…

Matched conditions: PLATINUM-RESISTANT FALLOPIAN TUBE CANCER

Phase 2 • Sponsor: Yale University • Aim: Disease control

Last updated Jun 27, 2026 09:10 UTC

Platinum-resistant fallopian tube cancer

Get alerted when new Platinum-resistant fallopian tube cancer trials appear

New hope for hard-to-treat ovarian cancer: targeted drug shows promise in early trial